Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| APTARGROUP, INC.ATR · Entity 165 | Director · President and CEO | August 03, 2026 | August 04, 2026 |
| Ingredion IncINGR · Entity 3745 | Director | May 20, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
APTARGROUP, INC.
Report date August 03, 2026 · Filed August 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 238,729 |
Ending reported balance
After 2026-08-03 transaction · row 3
2 source rows · reconciled sequenceRow 2 · 2026-08-03 · Exercise / conversion · Acquired 9,838 · Balance 248,567 Row 3 · 2026-08-03 · Sale · Disposed 9,838 · Balance 238,729 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.0000 to $136.5200 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $74.79 · Expires 2027-02-10 | Direct | 0 |
Reported balance
After 2026-08-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-08-03 · Exercise / conversion · Disposed 9,838 · Balance 0 |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) trust | 3,150 |
Reported balance
Holding disclosure · report date 2026-08-03 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 3,150 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.0000 to $136.5200 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth.
Ingredion Inc
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,797 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 1,797 · Balance 1,797 F1: These are restricted stock units ("RSUs") issued under the Ingredion Incorporated Stock Incentive Plan to the Company's outside directors as part of their annual retainer (as further described in Exhibit 10.26 to the Company's Annual Report on Form 10-K for the year ended December 31, 2025, filed on February 17, 2026). One portion of this grant covers the period from April 1, 2026 to May 19, 2026, and the remaining portion represents the full value of the outside directors' 2026 annual equity retainer, reflecting the Company's shift in 2026 from a calendar-year basis for director stock compensation to a twelve-month cycle aligned with the annual stockholder meeting. The RSUs may be settled only in shares of common stock (one share per RSU) and will vest on May 19, 2027, subject to the Committee's discretion to accelerate vesting upon an outside director's retirement, death, disability, or a Change in Control. |
| Common StockSEC Table I · non-derivative | Indirectthrough The Tanda Joint Living Trust | 10,737 |
Reported balance
Holding disclosure · report date 2026-05-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 10,737 |
Filing footnotes · ownership attribution and instrument terms
F1: These are restricted stock units ("RSUs") issued under the Ingredion Incorporated Stock Incentive Plan to the Company's outside directors as part of their annual retainer (as further described in Exhibit 10.26 to the Company's Annual Report on Form 10-K for the year ended December 31, 2025, filed on February 17, 2026). One portion of this grant covers the period from April 1, 2026 to May 19, 2026, and the remaining portion represents the full value of the outside directors' 2026 annual equity retainer, reflecting the Company's shift in 2026 from a calendar-year basis for director stock compensation to a twelve-month cycle aligned with the annual stockholder meeting. The RSUs may be settled only in shares of common stock (one share per RSU) and will vest on May 19, 2027, subject to the Committee's discretion to accelerate vesting upon an outside director's retirement, death, disability, or a Change in Control.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Patheon N.V.
Report date August 29, 2017 · Filed August 30, 2017
Section 16 reporting ended · disclosed 2017-08-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units (Ordinary Shares)SEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-08-29 transaction · row 1
1 source rowRow 1 · 2017-08-29 · Other · Disposed 4,659 · Balance 0 F1: Ordinary shares of Patheon N.V. ("Issuer") were disposed of pursuant to a tender offer by Thermo Fisher (CN) Luxembourg S.a r.l., a private limited liability company (societe a responsabilite limitee) organized under the laws of the Grand Duchy of Luxembourg ("Purchaser") and Thermo Fisher Scientific Inc., a Delaware corporation ("Thermo Fisher"), to acquire all of the issued and outstanding ordinary shares (the "Shares") of Issuer at a purchase price of $35.00 per Share, pursuant to the terms of the Purchase Agreement, dated as of May 15, 2017 (as it may be amended from time to time, the "Purchase Agreement"), by and between Issuer, Purchaser and Thermo Fisher. Pursuant to the terms of the Purchase Agreement, each vested restricted stock unit was canceled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit (continued in footnote 2) F2: upon the closing of the tender offer (with restricted stock units that are subject to performance conditions vesting based on achievement of actual performance conditions in accordance with the terms of the award). Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer. (continued in footnote 3) F3: The "Exchange Ratio" is 0.1996919, which represents the quotient obtained by dividing (i) $35.00 by (ii) the average closing price, rounded to the nearest cent, per share of common stock of Thermo Fisher on the NYSE for the consecutive period of ten (10) trading days immediately preceding (but not including) the date of the closing of the tender offer. F4: This amount represents 4,659 restricted stock units, each of which represented a contingent right to receive one Share of Issuer. Each restricted stock unit was canceled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit upon the closing of the tender offer. |
Filing footnotes · ownership attribution and instrument terms
F1: Ordinary shares of Patheon N.V. ("Issuer") were disposed of pursuant to a tender offer by Thermo Fisher (CN) Luxembourg S.a r.l., a private limited liability company (societe a responsabilite limitee) organized under the laws of the Grand Duchy of Luxembourg ("Purchaser") and Thermo Fisher Scientific Inc., a Delaware corporation ("Thermo Fisher"), to acquire all of the issued and outstanding ordinary shares (the "Shares") of Issuer at a purchase price of $35.00 per Share, pursuant to the terms of the Purchase Agreement, dated as of May 15, 2017 (as it may be amended from time to time, the "Purchase Agreement"), by and between Issuer, Purchaser and Thermo Fisher. Pursuant to the terms of the Purchase Agreement, each vested restricted stock unit was canceled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit (continued in footnote 2)
F2: upon the closing of the tender offer (with restricted stock units that are subject to performance conditions vesting based on achievement of actual performance conditions in accordance with the terms of the award). Each unvested restricted stock unit was cancelled and converted into a restricted stock unit award, with substantially the same terms and conditions (including with respect to vesting) as were applicable to such unvested restricted stock unit immediately prior to the closing of the tender offer, with respect to a number of shares of Thermo Fisher common stock equal to the product (rounded to the nearest whole share) obtained by multiplying (x) the Exchange Ratio by (y) the total number of Shares subject to the unvested restricted stock unit as of immediately prior to the closing of the tender offer. (continued in footnote 3)
F3: The "Exchange Ratio" is 0.1996919, which represents the quotient obtained by dividing (i) $35.00 by (ii) the average closing price, rounded to the nearest cent, per share of common stock of Thermo Fisher on the NYSE for the consecutive period of ten (10) trading days immediately preceding (but not including) the date of the closing of the tender offer.
F4: This amount represents 4,659 restricted stock units, each of which represented a contingent right to receive one Share of Issuer. Each restricted stock unit was canceled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit upon the closing of the tender offer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2024 Filed Oct 1, 2024 22:27 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 295 | $135.41 | $39,945.95 |
DisclosureSEC source: 0001127602-24-024758 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,454 F1 · shares: These are shares of common stock issued to the Company's outside directors as part of their annual retainer. Read SEC document |
| July 29, 2024 Filed Jul 30, 2024 16:15 UTC | APTARGROUP, INC. ATR · Entity 165 | Exercise / conversionStock Option · Derivative | 32,000 | $0.00 Strike: $74.79 | $0.00 |
DisclosureSEC source: 0001062993-24-014160 · form4.xml · derivative · entry 6 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,838 Underlying: Common Stock · 32,000 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2024 Filed Jul 30, 2024 16:15 UTC | APTARGROUP, INC. ATR · Entity 165 | SaleCommon Stock | 10,833 | $147.85 | $1,601,642.80 |
DisclosureSEC source: 0001062993-24-014160 · form4.xml · nonDerivative · entry 5 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,118 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.5000 to $148.2300 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth. Read SEC document |
| July 29, 2024 Filed Jul 30, 2024 16:15 UTC | APTARGROUP, INC. ATR · Entity 165 | SaleCommon Stock | 5,953 | $147.01 | $875,149.34 |
DisclosureSEC source: 0001062993-24-014160 · form4.xml · nonDerivative · entry 4 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,951 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.5000 to $147.4900 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth. Read SEC document |
| July 29, 2024 Filed Jul 30, 2024 16:15 UTC | APTARGROUP, INC. ATR · Entity 165 | SaleCommon Stock | 15,214 | $147.57 | $2,245,177.14 |
DisclosureSEC source: 0001062993-24-014160 · form4.xml · nonDerivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,904 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.1800 to $147.8450 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth. Read SEC document |
| July 29, 2024 Filed Jul 30, 2024 16:15 UTC | APTARGROUP, INC. ATR · Entity 165 | Exercise / conversionCommon Stock | 32,000 | $74.79 | $2,393,280.00 |
DisclosureSEC source: 0001062993-24-014160 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 17:01 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 346 | $115.36 | $39,914.56 |
DisclosureSEC source: 0001127602-24-019729 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,159 F1 · shares: These are shares of common stock issued to the Company's outside directors as part of their annual retainer. Read SEC document |
| April 26, 2024 Filed Apr 29, 2024 22:12 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 8,084 | $143.33 | $1,158,679.72 |
DisclosureSEC source: 0001062993-24-009012 · form4.xml · nonDerivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,118 Read SEC document |
| April 26, 2024 Filed Apr 29, 2024 22:12 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantCommon Stock | 18,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-009012 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,202 Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 21:04 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 342 | $116.81 | $39,949.02 |
DisclosureSEC source: 0001127602-24-011907 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,813 F1 · shares: These are shares of common stock issued to the Company's outside directors as part of their annual retainer. Read SEC document |
| March 22, 2024 Filed Mar 25, 2024 17:10 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 2,144 | $141.59 | $303,568.96 |
DisclosureSEC source: 0001062993-24-006989 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,956 Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 23:00 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantStock Option · Derivative | 45,219 | $0.00 Strike: $141.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006671 · form4.xml · derivative · entry 4 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,219 Underlying: Common Stock · 45,219 shares Expires 2034-03-15 F1 · derivative.exercise_date: The stock option vests in three equal installments beginning on the first anniversary of the grant date. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 23:00 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantCommon Stock | 11,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006671 · form4.xml · nonDerivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,100 Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 23:00 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 1,741 | $141.00 | $245,481.00 |
DisclosureSEC source: 0001062993-24-006671 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,500 Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 21:35 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 2,783 | $140.93 | $392,208.19 |
DisclosureSEC source: 0001062993-24-006538 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,241 Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 19:39 UTC | APTARGROUP, INC. ATR · Entity 165 | Exercise / conversionStock Option · Derivative | 32,000 | $0.00 Strike: $74.79 | $0.00 |
DisclosureSEC source: 0001062993-24-005408 · form4.xml · derivative · entry 5 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,838 Underlying: Common Stock · 32,000 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 19:39 UTC | APTARGROUP, INC. ATR · Entity 165 | SaleCommon Stock | 400 | $142.07 | $56,827.00 |
DisclosureSEC source: 0001062993-24-005408 · form4.xml · nonDerivative · entry 4 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,024 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.0550 to $142.0900 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 19:39 UTC | APTARGROUP, INC. ATR · Entity 165 | SaleCommon Stock | 31,600 | $141.66 | $4,476,566.60 |
DisclosureSEC source: 0001062993-24-005408 · form4.xml · nonDerivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,424 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.0500 to $142.0200 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 19:39 UTC | APTARGROUP, INC. ATR · Entity 165 | Exercise / conversionCommon Stock | 32,000 | $74.79 | $2,393,280.00 |
DisclosureSEC source: 0001062993-24-005408 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 21:37 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 3,733 | $141.92 | $529,787.36 |
DisclosureSEC source: 0001062993-24-004586 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,024 Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 19:58 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantCommon Stock | 6,679 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004420 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,757 Read SEC document |
| December 11, 2023 Filed Dec 12, 2023 22:57 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 360 | $103.99 | $37,436.40 |
DisclosureSEC source: 0001127602-23-029487 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,471 F1 · shares: These are shares of common stock issued to the Company's outside directors as part of their annual retainer. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 23:23 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 376 | $99.59 | $37,445.84 |
DisclosureSEC source: 0001127602-23-025384 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,111 F1 · shares: These are shares of common stock issued to the Company's outside directors as part of their annual retainer. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:37 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 354 | $105.95 | $37,506.30 |
DisclosureSEC source: 0001127602-23-020101 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 735 F1 · shares: These are shares of common stock issued to the Company's outside directors as part of their annual retainer. Read SEC document |
| April 28, 2023 Filed May 2, 2023 21:16 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 8,303 | $118.51 | $983,988.53 |
DisclosureSEC source: 0001062993-23-009935 · form4.xml · nonDerivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,078 Read SEC document |
| April 28, 2023 Filed May 2, 2023 21:16 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantCommon Stock | 18,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-009935 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,381 Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 21:34 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 381 | $98.41 | $37,494.21 |
DisclosureSEC source: 0001127602-23-012394 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 381 F1 · shares: These are shares of common stock issued to the Company's outside directors as part of their annual retainer. Read SEC document |
| March 23, 2023 Filed Mar 24, 2023 17:56 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 3,222 | $111.72 | $359,961.84 |
DisclosureSEC source: 0001062993-23-007602 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,642 Read SEC document |
| March 22, 2023 Filed Mar 23, 2023 16:09 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 2,143 | $112.25 | $240,551.75 |
DisclosureSEC source: 0001062993-23-007517 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,864 Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:04 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantStock Option · Derivative | 58,803 | $0.00 Strike: $122.52 | $0.00 |
DisclosureSEC source: 0001062993-23-007019 · form4.xml · derivative · entry 4 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,803 Underlying: Common Stock · 58,803 shares Expires 2033-03-15 F1 · derivative.exercise_date: The stock option vests in three equal installments beginning on the first anniversary of the grant date. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:04 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantCommon Stock | 11,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-007019 · form4.xml · nonDerivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,007 Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:04 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 2,783 | $115.08 | $320,267.64 |
DisclosureSEC source: 0001062993-23-007019 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,222 Read SEC document |
| February 25, 2023 Filed Mar 1, 2023 02:06 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 2,610 | $116.69 | $304,560.90 |
DisclosureSEC source: 0001062993-23-005218 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,005 Read SEC document |
| February 24, 2023 Filed Feb 27, 2023 20:04 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantCommon Stock | 8,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-004969 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,615 Read SEC document |
| February 10, 2023 Filed Feb 10, 2023 16:51 UTC | Ingredion Inc INGR · Entity 3745 | GiftCommon Stock | 1,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-004324 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · through The Tanda Joint Living Trust Disclosed balance after: 6,346 F1 · balance_after: On 2/10/23 the reporting person transferred 1,701 directly owned shares of Ingredion Incorporated common stock to The Tanda Joint Living Trust u/a/d 7/21/16 of which the insider and his spouse are the trustees and immediate family members are the beneficiaires. Read SEC document |
| February 10, 2023 Filed Feb 10, 2023 16:51 UTC | Ingredion Inc INGR · Entity 3745 | GiftCommon Stock | 1,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-004324 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 12:26 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 450 | $81.71 | $36,769.50 |
DisclosureSEC source: 0001127602-22-023613 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,701 F1 · shares: These are shares of common stock issued to the Company's outside directors as part of their annual retainer. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 21:05 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 422 | $88.77 | $37,460.94 |
DisclosureSEC source: 0001127602-22-018969 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,251 F1 · shares: These are shares of common stock issued to the Company's outside Directors as part of their annual retainer. F2 · balance_after: Includes shares of common stock acquired through dividend reinvestment. Read SEC document |
| April 29, 2022 Filed May 3, 2022 18:02 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 3,704 | $115.85 | $429,108.40 |
DisclosureSEC source: 0000905148-22-000359 · form4.xml · nonDerivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,683 Read SEC document |
| April 29, 2022 Filed May 3, 2022 18:02 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantCommon Stock | 8,359 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-22-000359 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,387 Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 19:00 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 438 | $85.56 | $37,475.28 |
DisclosureSEC source: 0001127602-22-011451 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 829 F1 · shares: These are shares of common stock issued to the Company's outside directors as part of their annual retainer. Read SEC document |
| March 25, 2022 Filed Mar 28, 2022 13:28 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 2,315 | $117.24 | $271,410.60 |
DisclosureSEC source: 0001062993-22-008690 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,028 Read SEC document |
| March 23, 2022 Filed Mar 24, 2022 16:22 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 3,221 | $114.67 | $369,352.07 |
DisclosureSEC source: 0001062993-22-008467 · form4.xml · nonDerivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,343 Read SEC document |
| March 22, 2022 Filed Mar 24, 2022 16:22 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 2,143 | $117.67 | $252,166.81 |
DisclosureSEC source: 0001062993-22-008467 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,564 Read SEC document |
| March 14, 2022 Filed Mar 15, 2022 20:53 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantCommon Stock | 18,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-007755 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,707 Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 01:00 UTC | APTARGROUP, INC. ATR · Entity 165 | GrantCommon Stock | 10,386 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005959 · form4.xml · nonDerivative · entry 3 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,862 Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 01:00 UTC | APTARGROUP, INC. ATR · Entity 165 | Tax withholdingCommon Stock | 1,033 | $120.97 | $124,962.01 |
DisclosureSEC source: 0001062993-22-005959 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,476 Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:36 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 391 | $97.12 | $37,973.92 |
DisclosureSEC source: 0001127602-22-000964 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391 F1 · shares: These are shares of common stock issued to the Company's outside directors as part of their annual retainer. Read SEC document |
| December 15, 2021 Filed Dec 15, 2021 19:33 UTC | Ingredion Inc INGR · Entity 3745 | GiftCommon Stock | 2,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-030962 · form4.xml · nonDerivative · entry 2 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · through The Tanda Joint Living Trust Disclosed balance after: 4,645 F1 · balance_after: On 12/15/21 the reporting person transferred 2,323 directly owned shares of Ingredion Incorporated common stock to The Tanda Joint Living Trust u/a/d/ 7/21/16 of which the insider and his spouse are the trustees and immediate family members are the beneficiaries. Read SEC document |
| December 15, 2021 Filed Dec 15, 2021 19:33 UTC | Ingredion Inc INGR · Entity 3745 | GiftCommon Stock | 2,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-030962 · form4.xml · nonDerivative · entry 1 Tanda Stephan B. · CIK 0001679516 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.